The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial
Year: 2024
Type: article
Study design: Clinical Trial
Source: Journal of Autoimmunity
Authors: Roberta Lorenzon, Claire Ribet, Fabien Pitoiset, Selim Aractingi, Beatrice Banneville, Laurent Beaugerie, Francis Berenbaum, Patrice Cacoub, Julien Champey, Olivier Chazouilleres, Christophe Corpechot, Bruno Fautrel, Arsène Mekinian, Elodie Regnier, David Saadoun, Joe-Elie Salem, Jérémie Sellam, Philippe Seksik, Eric Vicaut, Michelle Rosenzwajg, David Klatzmann
Institutions: Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Immunologie - Immunopathologie - Immunothérapie, Hôpital Cochin, Hôpital Saint-Antoine, Université Pierre-et-Marie-Curie, Institut Pierre Louis d‘Épidémiologie et de Santé Publique, Hôpital Fernand-Widal, Hôpital Lariboisière
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Award: G6241107499
OpenAlex ID: W4391629554